Success Metrics

Clinical Success Rate
60.0%

Based on 9 completed trials

Completion Rate
60%(9/15)
Active Trials
2(11%)
Results Posted
78%(7 trials)
Terminated
6(33%)

Phase Distribution

Ph phase_2
8
44%
Ph not_applicable
3
17%
Ph early_phase_1
1
6%
Ph phase_1
4
22%
Ph phase_4
2
11%

Phase Distribution

5

Early Stage

8

Mid Stage

2

Late Stage

Phase Distribution18 total trials
Early Phase 1First-in-human
1(5.6%)
Phase 1Safety & dosage
4(22.2%)
Phase 2Efficacy & side effects
8(44.4%)
Phase 4Post-market surveillance
2(11.1%)
N/ANon-phased studies
3(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

56.3%

9 of 16 finished

Non-Completion Rate

43.8%

7 ended early

Currently Active

2

trials recruiting

Total Trials

18

all time

Status Distribution
Active(2)
Completed(9)
Terminated(7)

Detailed Status

Completed9
Terminated6
Recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
18
Active
2
Success Rate
60.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (5.6%)
Phase 14 (22.2%)
Phase 28 (44.4%)
Phase 42 (11.1%)
N/A3 (16.7%)

Trials by Status

recruiting211%
completed950%
terminated633%
withdrawn16%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials
NCT06307548Phase 1

Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer

Recruiting
NCT02728388Phase 2

Photodynamic Therapy for Benign Dermal Neurofibromas- Phase II

Recruiting
NCT06252727Phase 1

Fluorescent Aided Resection and Evaluation of Soft Tissue Sarcomas (FLARES)

Withdrawn
NCT03327831Phase 4

Study of Daylight Photodynamic Therapy With Aminolevulinic Acid for Actinic Keratoses

Completed
NCT00752323Phase 2

Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma

Completed
NCT02464709Phase 4

Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)

Completed
NCT00961090Phase 2

Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery

Completed
NCT02594644Not Applicable

The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy

Completed
NCT02239679Phase 2

Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy

Completed
NCT01575275Phase 2

Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme

Terminated
NCT01812837Not Applicable

The Use of Microneedles in Photodynamic Therapy

Completed
NCT00524485Not Applicable

Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis

Terminated
NCT01148966Phase 1

Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors

Terminated
NCT00663910Early Phase 1

Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer

Terminated
NCT01351519Phase 2

A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors

Terminated
NCT00002975Phase 2

Photodynamic Therapy in Treating Patients With Skin Cancer

Completed
NCT00865878Phase 2

ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients

Terminated
NCT00671710Phase 1

Study of Aminolevulinic Acid to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain

Completed

All 18 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
18